Sunitinib induced hypothyroidism: a retrospective analysis

Koteshwara Muralidhara, Jake Powrie(Guy's and St Thomas' NHS Foundation Trust), Rustom Guzder, Debra L. Joseph, Paul Carroll, Sarah Rudman(Guy's and St Thomas' NHS Foundation Trust), Simon Chowdhury(Sarah Cannon Research Institute), Barbara McGowan(Guy's and St Thomas' NHS Foundation Trust)
Society for Endocrinology BES 2010
March 31, 2010
Cited by 0

Related Papers

Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
|The Lancet|2015|2k
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy
|New England Journal of Medicine|2017|1.8k
Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal
|Cell|2018|883
Deterministic Evolutionary Trajectories Influence Primary Tumor Growth: TRACERx Renal
|Cell|2018|680